Common Contracts
3 similar Series a-2 Preferred Stock Purchase Agreement contracts by Cancer Prevention Pharmaceuticals, Inc.
CANCER PREVENTION PHARMACEUTICALS, INC. SERIES A-2 PREFERRED STOCK PURCHASE AGREEMENTSeries a-2 Preferred Stock Purchase Agreement • September 4th, 2015 • Cancer Prevention Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Series A-2 Preferred Stock Purchase Agreement (this “Agreement”) dated as of September __, 2012 is between Cancer Prevention Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the persons (each, an “Investor” and collectively, the “Investors”) listed on the Schedule of Investors attached as Exhibit A (the “Schedule of Investors”).
CANCER PREVENTION PHARMACEUTICALS, INC. SERIES A-2 PREFERRED STOCK PURCHASE AGREEMENTSeries a-2 Preferred Stock Purchase Agreement • September 4th, 2015 • Cancer Prevention Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Series A-2 Preferred Stock Purchase Agreement (this “Agreement”) dated as of November 19, 2012 is between Cancer Prevention Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the persons (each, an “Investor” and collectively, the “Investors”) listed on the Schedule of Investors attached as Exhibit A (the “Schedule of Investors”).
CANCER PREVENTION PHARMACEUTICALS, INC. SERIES A-2 PREFERRED STOCK PURCHASE AGREEMENTSeries a-2 Preferred Stock Purchase Agreement • September 4th, 2015 • Cancer Prevention Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Amended Series A-2 Preferred Stock Purchase Agreement (this “Agreement”) dated as of July 12, 2013 is between Cancer Prevention Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the persons (each, an “Investor” and collectively, the “Investors”) listed on the Schedule of Investors attached as Exhibit A (the “Schedule of Investors”).
